133 related articles for article (PubMed ID: 17018874)
1. Metallothionein as a prognostic biomarker in breast cancer.
Bay BH; Jin R; Huang J; Tan PH
Exp Biol Med (Maywood); 2006 Oct; 231(9):1516-21. PubMed ID: 17018874
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of metallothioneins in breast cancer.
Jin R; Huang J; Tan PH; Bay BH
Pathol Oncol Res; 2004; 10(2):74-9. PubMed ID: 15188022
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein 2A expression is associated with cell proliferation in breast cancer.
Jin R; Chow VT; Tan PH; Dheen ST; Duan W; Bay BH
Carcinogenesis; 2002 Jan; 23(1):81-6. PubMed ID: 11756227
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
5. Targeting metallothionein for prognosis and treatment of breast cancer.
Lai Y; Yip GW; Bay BH
Recent Pat Anticancer Drug Discov; 2011 May; 6(2):178-85. PubMed ID: 21449882
[TBL] [Abstract][Full Text] [Related]
6. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
7. Correlation between metallothionein (MT) expression and selected prognostic factors in ductal breast cancers.
Gomulkiewicz A; Podhorska-Okolow M; Szulc R; Smorag Z; Wojnar A; Zabel M; Dziegiel P
Folia Histochem Cytobiol; 2010 Jan; 48(2):242-8. PubMed ID: 20675281
[TBL] [Abstract][Full Text] [Related]
8. Elevated metallothionein (MT) expression in invasive ductal breast cancers predicts tamoxifen resistance.
Surowiak P; Matkowski R; Materna V; Györffy B; Wojnar A; Pudelko M; Dziegiel P; Kornafel J; Zabel M
Histol Histopathol; 2005 Oct; 20(4):1037-44. PubMed ID: 16136485
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein isoform 3 as a potential biomarker for human bladder cancer.
Sens MA; Somji S; Lamm DL; Garrett SH; Slovinsky F; Todd JH; Sens DA
Environ Health Perspect; 2000 May; 108(5):413-8. PubMed ID: 10811567
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant.
Tai SK; Tan OJ; Chow VT; Jin R; Jones JL; Tan PH; Jayasurya A; Bay BH
Am J Pathol; 2003 Nov; 163(5):2009-19. PubMed ID: 14578200
[TBL] [Abstract][Full Text] [Related]
11. Expression of Metallothionein and Vascular Endothelial Growth Factor Isoforms in Breast Cancer Cells.
Wierzowiecka B; Gomulkiewicz A; Cwynar-Zajac L; Olbromski M; Grzegrzolka J; Kobierzycki C; Podhorska-Okolow M; Dziegiel P
In Vivo; 2016; 30(3):271-8. PubMed ID: 27107086
[TBL] [Abstract][Full Text] [Related]
12. Significance of metallothionein expression in breast myoepithelial cells.
Jin R; Bay BH; Chow VT; Tan PH; Dheen T
Cell Tissue Res; 2001 Feb; 303(2):221-6. PubMed ID: 11291768
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of metallothionein predicts chemoresistance in breast cancer.
Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
[TBL] [Abstract][Full Text] [Related]
14. Lack of relationship between metallothionein (MT) expression and proliferation exponents in cells of primary ductal breast cancer of G2 grade of differentiation.
Surowiak P; Paluchowski P; Dziegiel P; Wysocka T; Wojnar A; Spaczyński M; Zabel M
Med Sci Monit; 2004 Aug; 10(8):BR300-5. PubMed ID: 15277992
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein isoforms as double agents - Their roles in carcinogenesis, cancer progression and chemoresistance.
Merlos Rodrigo MA; Jimenez Jimemez AM; Haddad Y; Bodoor K; Adam P; Krizkova S; Heger Z; Adam V
Drug Resist Updat; 2020 Sep; 52():100691. PubMed ID: 32615524
[TBL] [Abstract][Full Text] [Related]
16. Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.
Ostrakhovitch EA; Song YP; Cherian MG
J Trace Elem Med Biol; 2016 May; 35():18-29. PubMed ID: 27049123
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of human metallothionein isoforms: a family of small, highly conserved, cysteine-rich proteins.
Mehus AA; Muhonen WW; Garrett SH; Somji S; Sens DA; Shabb JB
Mol Cell Proteomics; 2014 Apr; 13(4):1020-33. PubMed ID: 24493013
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of metallothionein isoform 1 and 2 expression in the human breast and the MCF-10A cell line.
Gurel V; Sens DA; Somji S; Garrett SH; Weiland T; Sens MA
Toxicol Sci; 2005 Jun; 85(2):906-15. PubMed ID: 15788722
[TBL] [Abstract][Full Text] [Related]
19. Metallothioneins in the lung cancer.
Werynska B; Pula B; Kobierzycki C; Dziegiel P; Podhorska-Okolow M
Folia Histochem Cytobiol; 2015; 53(1):1-10. PubMed ID: 25815626
[TBL] [Abstract][Full Text] [Related]
20. Expression of metallothionein in invasive ductal breast cancer in relation to prognosis.
Zhang R; Zhang H; Wei H; Luo X
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):95-7. PubMed ID: 10905514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
